JP2022505143A5 - - Google Patents
Info
- Publication number
- JP2022505143A5 JP2022505143A5 JP2021521058A JP2021521058A JP2022505143A5 JP 2022505143 A5 JP2022505143 A5 JP 2022505143A5 JP 2021521058 A JP2021521058 A JP 2021521058A JP 2021521058 A JP2021521058 A JP 2021521058A JP 2022505143 A5 JP2022505143 A5 JP 2022505143A5
- Authority
- JP
- Japan
- Prior art keywords
- benzofuran
- dione
- compound according
- ethyl
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18200626 | 2018-10-16 | ||
| EP18200626.2 | 2018-10-16 | ||
| PCT/GB2019/052937 WO2020079422A1 (en) | 2018-10-16 | 2019-10-16 | Novel compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022505143A JP2022505143A (ja) | 2022-01-14 |
| JP2022505143A5 true JP2022505143A5 (enExample) | 2022-10-25 |
| JP7465868B2 JP7465868B2 (ja) | 2024-04-11 |
Family
ID=63878368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521058A Active JP7465868B2 (ja) | 2018-10-16 | 2019-10-16 | 新規化合物 |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP3867247B1 (enExample) |
| JP (1) | JP7465868B2 (enExample) |
| KR (1) | KR102854594B1 (enExample) |
| AR (1) | AR116713A1 (enExample) |
| AU (1) | AU2019360017B9 (enExample) |
| BR (1) | BR112021006940A2 (enExample) |
| DK (1) | DK3867247T3 (enExample) |
| ES (1) | ES2988842T3 (enExample) |
| FI (1) | FI3867247T3 (enExample) |
| HR (1) | HRP20241318T1 (enExample) |
| HU (1) | HUE068686T2 (enExample) |
| IL (1) | IL282096B2 (enExample) |
| LT (1) | LT3867247T (enExample) |
| MX (1) | MX2021004386A (enExample) |
| PL (1) | PL3867247T3 (enExample) |
| PT (1) | PT3867247T (enExample) |
| SI (1) | SI3867247T1 (enExample) |
| TW (1) | TWI827706B (enExample) |
| WO (1) | WO2020079422A1 (enExample) |
| ZA (1) | ZA202101487B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12358901B2 (en) | 2018-10-16 | 2025-07-15 | Autifony Therapeutics Limited | KV3 modulators |
| JP7522203B2 (ja) * | 2020-02-06 | 2024-07-24 | アウトイフオンイ トヘラペウトイクス リミテッド | Ｋｖ３モジュレーター |
| CA3228446A1 (en) | 2021-08-09 | 2023-02-16 | Janssen Pharmaceutica Nv | Monoacylglycerol lipase modulators for use in autism spectrum disorders |
| US20240327406A1 (en) | 2021-08-10 | 2024-10-03 | Autifony Therapeutics Limited | Potassium channel modulators |
| EP4630117A1 (en) | 2022-12-06 | 2025-10-15 | Autifony Therapeutics Limited | Compounds for the treatment of centra nervous system disorders |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5788404B2 (ja) | 2009-12-11 | 2015-09-30 | アウトイフオンイ トヘラペウトイクス リミテッド | イミダゾリジンジオン誘導体 |
| EP2649066B1 (en) | 2010-12-06 | 2015-10-21 | Autifony Therapeutics Limited | Hydantoin derivatives useful as kv3 inhibitors |
| US9193704B2 (en) | 2011-06-07 | 2015-11-24 | Autifony Therapeutics Limited | Hydantoin derivatives as KV3 inhibitors |
| GB201209986D0 (en) | 2012-06-06 | 2012-07-18 | Autifony Therapeutics Ltd | Novel compounds |
| AU2012349847B2 (en) | 2011-12-06 | 2017-02-16 | Autifony Therapeutics Limited | Hydantoin derivatives useful as Kv3 inhibitors |
| EP2852588B8 (en) | 2012-05-22 | 2018-01-10 | Autifony Therapeutics Limited | Hydantoin derivatives as kv3 inhibitors |
| US9422252B2 (en) | 2012-05-22 | 2016-08-23 | Autifony Therapeutics Limited | Triazoles as Kv3 inhibitors |
| WO2013182851A1 (en) | 2012-06-06 | 2013-12-12 | Autifony Therapeutics Limited | Prophylaxis or treatment of diseases where a modulator of kv3.3 channels is required |
| GB201521751D0 (en) | 2015-12-10 | 2016-01-27 | Autifony Therapeutics Ltd | Novel uses |
| GB201522179D0 (en) | 2015-12-16 | 2016-01-27 | Autifony Therapeutics Ltd | Novel compounds |
| GB201613163D0 (en) | 2016-07-29 | 2016-09-14 | Autifony Therapeutics Ltd | Novel compounds |
| WO2018109484A1 (en) | 2016-12-16 | 2018-06-21 | Autifony Therapeutics Limited | Hydantoin modulators of kv3 channels |
-
2019
- 2019-10-16 TW TW108137290A patent/TWI827706B/zh active
- 2019-10-16 ES ES19790048T patent/ES2988842T3/es active Active
- 2019-10-16 HR HRP20241318TT patent/HRP20241318T1/hr unknown
- 2019-10-16 BR BR112021006940-2A patent/BR112021006940A2/pt unknown
- 2019-10-16 PL PL19790048.3T patent/PL3867247T3/pl unknown
- 2019-10-16 PT PT197900483T patent/PT3867247T/pt unknown
- 2019-10-16 IL IL282096A patent/IL282096B2/en unknown
- 2019-10-16 WO PCT/GB2019/052937 patent/WO2020079422A1/en not_active Ceased
- 2019-10-16 HU HUE19790048A patent/HUE068686T2/hu unknown
- 2019-10-16 DK DK19790048.3T patent/DK3867247T3/da active
- 2019-10-16 SI SI201930828T patent/SI3867247T1/sl unknown
- 2019-10-16 MX MX2021004386A patent/MX2021004386A/es unknown
- 2019-10-16 FI FIEP19790048.3T patent/FI3867247T3/fi active
- 2019-10-16 KR KR1020217014348A patent/KR102854594B1/ko active Active
- 2019-10-16 EP EP19790048.3A patent/EP3867247B1/en active Active
- 2019-10-16 AR ARP190102939A patent/AR116713A1/es unknown
- 2019-10-16 JP JP2021521058A patent/JP7465868B2/ja active Active
- 2019-10-16 LT LTEPPCT/GB2019/052937T patent/LT3867247T/lt unknown
- 2019-10-16 AU AU2019360017A patent/AU2019360017B9/en active Active
-
2021
- 2021-03-04 ZA ZA2021/01487A patent/ZA202101487B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022505143A5 (enExample) | ||
| JP2013544873A5 (enExample) | ||
| JP2019502696A5 (enExample) | ||
| JP2016145215A5 (enExample) | ||
| US11040035B2 (en) | 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides | |
| HRP20241318T1 (hr) | Novi spojevi | |
| ES2675022T3 (es) | Inhibidores de indolamina 2,3-dioxigenasa (IDO) | |
| AU2011240131B2 (en) | Arylethynyl derivatives | |
| JP3558088B2 (ja) | トロポン−置換のフェニルオキサゾリジノン抗菌剤 | |
| JP2014516073A5 (enExample) | ||
| HRP20200401T1 (hr) | Spojevi i postupci za tretiranje bakterijskih infekcija | |
| AU2024204310A1 (en) | Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disorders | |
| EP3414239A2 (en) | Inhibitors of receptor-interacting protein kinase 1 | |
| MX2009005449A (es) | Compuesto heteromonociclico y uso del mismo. | |
| JP2020502092A5 (enExample) | ||
| JP5461410B2 (ja) | ドーパミンｄ３受容体のモジュレーターとしてのアザビシクロ［３．１．０］ヘキシル誘導体 | |
| JP2015517563A5 (enExample) | ||
| JP2004505085A5 (enExample) | ||
| JP2020520925A5 (enExample) | ||
| JP2015502951A5 (enExample) | ||
| WO2013192125A1 (en) | Pyrazolyl derivatives as syk inhibitors | |
| JP2016511258A5 (enExample) | ||
| WO2019012093A1 (en) | INHIBITORS OF REACTION KINASE 2 RICH IN LEUCINE | |
| JP2017523223A5 (enExample) | ||
| RU2011105058A (ru) | Производные цетрагидроциннолина |